See All Slides - tctmd.com

Slides

Presentation TCT 2022

Changing the TAVR Paradigm (Solopace)

Presenter: David Daniels

September 17, 2022

Presentation TCT 2022

TCT 214: Single Ablation Renal Denervation – The RADAR Study Experience with the Metavention iRF System

Presenter: Horst Sievert

September 17, 2022

Presentation TCT 2022

TCT 58: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final: 5 Year Clinical Outcomes

Presenter: Matthias Lutz

September 17, 2022

Presentation TCT 2022

TCT 21: Preferred Strategy in the Era of Short-Term Dual Antiplatelet Therapy: A Systematic Review and Network Meta-Analysis of Randomized Trials

Presenter: Toshiki Kuno

September 17, 2022

Presentation TCT 2022

Opportunities to Improve Outcomes: IVUS

Presenter: Sahil Parikh

September 17, 2022

Presentation TCT 2022

TCT 775: AORTIC PARAVALVULAR LEAK AFTER SURGICAL AORTIC VALVE REPLACEMENT TREATED WITH BALLOON AORTIC VALVULOPLASTY FOLLOWED BY PLUG CLOSURE

Presenter: Juan Pablo Salazar

September 17, 2022

Presentation TCT 2022

Is TAV–in–Valve (Repeatability) More Important than Leaflet Durability?

Presenter: Ole De Backer

September 17, 2022

Presentation TCT 2022

TCT 212: Twenty-Four Month Results in Patients with Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial

Presenter: Roland Schmieder

September 17, 2022

Presentation TCT 2022

TCT 57: Everolimus-eluting Bioresorbable Vascular Scaffolds for Coronary Atherosclerosis Restoration Therapy: Insights on Long-term Intracoronary Imaging and Physiological Results of Bioresorption

Presenter: Gabriele Pesarini

September 17, 2022

Presentation TCT 2022

TCT 20: Relative benefit of double versus triple antithrombotic therapy in patients with atrial fibrillation randomized earlier versus later after index coronary event: Insights from the AUGUSTUS Trial

Presenter: Alexander Fanaroff

September 17, 2022

Advertisement

Slides

Changing the TAVR Paradigm (Solopace)

TCT 214: Single Ablation Renal Denervation – The RADAR Study Experience with the Metavention iRF System

TCT 58: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final: 5 Year Clinical Outcomes

TCT 21: Preferred Strategy in the Era of Short-Term Dual Antiplatelet Therapy: A Systematic Review and Network Meta-Analysis of Randomized Trials

Opportunities to Improve Outcomes: IVUS

TCT 775: AORTIC PARAVALVULAR LEAK AFTER SURGICAL AORTIC VALVE REPLACEMENT TREATED WITH BALLOON AORTIC VALVULOPLASTY FOLLOWED BY PLUG CLOSURE

Is TAV–in–Valve (Repeatability) More Important than Leaflet Durability?

TCT 212: Twenty-Four Month Results in Patients with Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial

TCT 57: Everolimus-eluting Bioresorbable Vascular Scaffolds for Coronary Atherosclerosis Restoration Therapy: Insights on Long-term Intracoronary Imaging and Physiological Results of Bioresorption

TCT 20: Relative benefit of double versus triple antithrombotic therapy in patients with atrial fibrillation randomized earlier versus later after index coronary event: Insights from the AUGUSTUS Trial

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content